Why Gradual Reduction of Antipsychotics Could Be Safer for Service Users
A new commentary published in Current Opinion in Psychiatry presents the case for slow tapering of antipsychotics. According to authors Mark Horowitz and Joanna...
Antidepressants Cause Cardiovascular Disease, Study Finds
A new study published in BMJ Mental Health finds that antidepressants are associated with cardiovascular disease (CVD). The authors employed Mendelian randomization, a method...
Study Finds No Increased Risks for Pregnant Women Who Discontinue SSRIs/SNRIs
A new article published in Pharmacy and Clinical Pharmacology finds pregnant women that chose to stop using selective serotonin reuptake inhibitors (SSRIs) and serotonin...
Study Finds Over 25% of Antidepressant Prescriptions Given to High-Risk, Long-Term Users
A new article published in BMC Medicine finds that antidepressant use in two Scottish regions increased 27% between 2012 and 2019. The current work,...
Antidepressants Linked to Lasting Sexual Dysfunction, Study Finds
New research highlights the challenges in quantifying the prevalence of Post-SSRI Sexual Dysfunction (PSSD), a condition that continues to affect patients long after they stop taking antidepressants.
ADHD Drugs Linked to Psychosis and Mania
In one analysis, those on a high dose of prescription amphetamines were more than 13 times more likely to develop psychosis/mania.
Antidepressant Withdrawal: A Psychiatrist’s 30-Year Challenge to Conventional Wisdom
For thirty years, Dr. Giovanni Fava has sounded the alarm on the long-term effects of antidepressants and the risks of withdrawal, pushing back against pharmaceutical narratives.
Antidepressant Withdrawal Commonly Misdiagnosed as “Mental Illness”
A new study reveals that more than two-thirds of patients experiencing antidepressant withdrawal were misdiagnosed with psychiatric disorders.
Antidepressants Overprescribed to Post-Menopausal Women Despite Risks
A new study reveals that antidepressants, commonly prescribed to post-menopausal women, may increase risks of falls, cognitive decline, and cardiovascular issues, raising questions about their overuse in this population.
The Ethics of Antipsychotic Dose Reduction and Patient Rights
New research highlights the ethical responsibilities of clinicians in supporting patients who choose to reduce or discontinue antipsychotic medication.
Beyond Paternalism or Abandonment in Mental Health Care: An Interview with Neil Gong
Neil Gong exposes the false choice in mental health policy between tolerant containment for the poor and paternalistic surveillance for the rich.
Youth Antipsychotic Use Linked to Increased Risk of Death within Five Years
Those aged 18-24 had an increased risk of death within five years on doses above 100 mg chlorpromazine equivalents.
Antiseizure Drug Exposure in Pregnancy Linked to Large Risk of Autism, ADHD, and Intellectual...
Harms are “largely overlooked by psychiatry despite widespread usage,” according to the researchers.
Remembering Bhargavi Davar: A Global Leader in the Struggle for Human Rights
Bhargavi Davar was a global leader in the struggle for human rights, with her work as a psychiatric survivor activist simply one aspect of that work.
Demedicalizing Depression: An Interview with Milutin Kostić
Justin Karter interviews Milutin Kostić on the fundamental flaws in depression research and its neglect of human complexity.
Wunderink: Antipsychotics Can Be Tapered Safely Without Increasing Relapse Risk
Tapering antipsychotics slowly and with supported decision-making may improve care for patients with psychosis.
Case Studies Reveal Patient Empowerment Through Tapering Antipsychotics
A new study shows how different patients respond to tapering antipsychotic medication under expert guidance, highlighting personal empowerment and the complexities of withdrawal.
Long-Term Benzo Use Linked to Increased Disability
Despite guidance that the drugs should only be used short-term, about a third of patients indicated long-term benzo use.
When Medication Changes More Than Symptoms: Antipsychotics’ Effect on Identity
Recent research reveals how antipsychotic medications can significantly impact users' identity and self-image, challenging existing clinical approaches.
Study Links Prenatal Antipsychotic Exposure to Developmental Delays and ADHD
A comprehensive review indicates that children exposed to antipsychotics in the womb face an increased risk of ADHD and developmental delays.
Long-term Outcomes Better for Those Who Stop Taking Antipsychotics
Research undermines the prolonged use of antipsychotics in schizophrenia treatment, suggesting improved social functioning and quality of life with discontinuation.
Antidepressant Use in Pregnancy Harms Child Development, Untreated Maternal Depression Shows Benefit
In this new study, exposure to maternal anxiety in utero also harmed child development.
Deprescribing Psychiatric Drugs to Reduce Harms and Empower Patients: Interview with Psychiatrist Swapnil Gupta
Ayurdhi Dhar interviews psychiatrist Swapnil Gupta on psychiatric drug discontinuation, drug cocktail risks, patient choice, and the need for trust and transparency.
Study Highlights Difficulty of Antipsychotic Withdrawal
New research finds insomnia, anxiety, and depression are common symptoms of antipsychotic withdrawal, highlighting difficulties of discontinuation.
Common Side Effects Leading to Antidepressant Discontinuation
New research finds the negative drug effects most commonly associated with initiating antidepressant discontinuation are anxiety, suicidal thoughts, vomiting, and rashes.
